Published in Obesity and Diabetes Week, December 22nd, 2003
Release of the product will occur simultaneous with the release of metformin HCl by another generic company. Metformin HCl extended release is the generic version of Bristol-Myers Squibb's Glucophage XR 500 mg tablets.
Glucophage XR is used in the treatment of type 2 diabetes and has annual U.S. sales of approximately $450 million.
"We are pleased to now include metformin extended-release tablets among our many product offerings," said Scott...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.